The incidence of early-onset colorectal cancer (EO-CRC; diagnosed before age 50 years) is increasing worldwide. Although current data indicate that EO-CRC may be biologically distinct from average-onset CRC (AO-CRC; diagnosed at age ≥50 years), molecular differences remain poorly defined. To address this knowledge gap,...
Caroline B. M. Porter, Shane P. Murphy, Jules Cazaubiel et al.· Nature Medicine· 0 citations
It is found that pre-diagnostic plasma proteomics identified proteins and pathways with modest effect sizes and clear differences between future risk of colon and rectal cancer and motivate site-specific biomarker discovery that distinguishes colon from rectal cancer.
Xin-Yuan Zhang, Jonathan M. Downie, D. Drew et al.· Journal of the National Canc...· 0 citations
This review synthesizes current evidence on the TiME of EOCRC and contrast it with that of conventional LOCRC, and explores how these insights inform immune-based prevention and immunotherapy strategies, including checkpoint blockade and rational combinations in the predominant microsatellite-stable EOCRC population.
José Perea, María González-Sanmartín, M. Coiras et al.· Cancer immunology research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.